| Literature DB >> 27488343 |
Emily White Johansson1, Katarina Ekholm Selling2, Humphreys Nsona3, Bonnie Mappin4, Peter W Gething4, Max Petzold5, Stefan Swartling Peterson2,6,7, Helena Hildenwall6.
Abstract
BACKGROUND: There are growing concerns about irrational antibiotic prescription practices in the era of test-based malaria case management. This study assessed integrated paediatric fever management using malaria rapid diagnostic tests (RDT) and Integrated Management of Childhood Illness (IMCI) guidelines, including the relationship between RDT-negative results and antibiotic over-treatment in Malawi health facilities in 2013-2014.Entities:
Keywords: Antibiotic resistance; Child health; Diagnosis; Fever case management; IMCI; Malaria
Mesh:
Substances:
Year: 2016 PMID: 27488343 PMCID: PMC4972956 DOI: 10.1186/s12936-016-1439-7
Source DB: PubMed Journal: Malar J ISSN: 1475-2875 Impact factor: 2.979
Fig. 1Study sample
Description of integrated paediatric fever management variables
| Description | |
|---|---|
|
| |
| Fever | During the exit interview, the caregiver is separately asked about each of the main symptoms or danger signs listed here |
| Cough or difficult breathing (CDB) | |
| Watery or frequent stools | |
| Danger signs (any below): | |
| Lethargy or excessive sleepiness | |
| Vomits everything | |
| Convulsions | |
| Inability to drink, eat or breastfeed | |
| Ear problem | During the exit interview, the caregiver is subsequently asked about other reasons for bringing the child to this facility today and the response categories are listed here |
| Eye problem | |
| Skin problem | |
| Other issue | |
|
| |
| Asked about or mentioned (insert complaint) | During the consultation, the interviewer silently records the performance of physical examinations. Those listed here are general assessments for presenting complaints of fever, cough or difficult breathing or diarrhea. Assessments reported in this paper are those based on Malawi IMCI algorithms unless otherwise noteda |
| Took the child’s temperature or felt body for hotness | |
| Counter respiration (breaths) for 60 s | |
| Checked skin turgor for dehydration | |
| Checked pallor by looking at palmsa | |
| Looked into the child’s moutha | |
| Checked for neck stiffness | |
| Undressed child (up to shoulders/down to ankles)a | |
|
| |
| RDT-confirmed malaria | After the consultation, the provider is asked if a malaria RDT was conducted anywhere in the facility prior to coming into the consultation room that day and if so, the provider is asked to report the test result if seen |
| IMCI-classified non-severe pneumonia | During the exit interview, there is a limited re-examination conducted by a trained provider that includes a 60-s respiratory rate count if cough or difficult breathing is present. IMCI-pneumonia classification (non-severe) is defined as reported cough or difficult breathing and a respiratory rate of 50 breaths or more per minute (2 up to 12 months) or 40 breaths or more per minute (12 months up to 5 years) |
| Clinical diarrhoea | During the consultation, the following recorded diagnoses for diarrhea or dehydration are included in this definition: diarrhoea, dysentery, amoebiasis, other digestive/intestinal issue, mild dehydration, moderate dehydration or severe dehydration |
|
| |
| Anti-malarial prescriptions | After the consultation, the provider is asked to report treatments prescribed to the client and a hierarchical coding was used to assign the more appropriate prescription to the observation. First-line anti-malarial prescription is defined as artemether/artesunate (oral, injection or suppository) or ACT/AL (oral). Second-line is quinine (oral or injection), amodiaquine (oral), fansidar (oral) or other anti-malarial (oral or injection). Anti-malarial over-treatment is any anti-malarial prescription for an RDT-negative result |
| Antibiotic prescriptions | After the consultation, the provider is asked to report treatments prescribed to the client and a hierarchical coding was used to assign the more appropriate prescription to the observation. First-line antibiotic prescription is defined as benzyl penicillin injection or amoxicillin (capsule or syrup). Second-line is cotrimoxazole (syrup or tablet) or other antibiotic (injection, syrup or capsule). Antibiotic over-treatment is the main outcome and is defined in the text |
| ORS and zinc prescriptions | After the consultation, the provider is asked to report treatments prescribed to the client. ORS and zinc is defined as a prescription of zinc and [home ORT (plan A) or initial ORT in facility (plan B) or intravenous fluids (plan C)] |
a Checked for palm pallor, looked into child’s mouth and undressed child to examine (up to shoulders/down to ankles) are general fever assessments for rash, petechiae due to meningitis or other febrile causes
Description of input variables in the antibiotic over-treatment analysis
| Input | Description | Source |
|---|---|---|
| Main | ||
| RDT done | RDT done prior to consultation (yes or no) | Provider interview |
| RDT result | RDT result (positive or negative) | Provider interview |
| Patient | ||
| Caregiver sex | Gender (male or female) | Exit interview |
| Child sex | Gender (male or female) | Observation |
| Caregiver age | Age (numeric: 11–74 years) | Exit interview |
| Diarrhoea | Diarrhea complaint (yes or no) | Exit interview |
| CDB | Cough or difficult breathing (yes or no) | Exit interview |
| Danger sign | Any danger sign complaint (yes or no) | Exit interview |
| Temperature | Temperature (numeric: 35°–40.8°) | Re-examination |
| Illness duration | Illness duration (numeric: 0–60 days) | Exit interview |
| Nearest facility | Nearest facility to home (yes or no) | Exit interview |
| Clinical examination | Counted breaths for 60 s (yes or no) | Observation |
| Consultation length | Derived from consultation start and end times (numeric: 0–307 min) | Observation |
| Consultation start hour | Derived from consultation start time (numeric: 7:00–17:00) | Observation |
| Wait time | Reported wait from arrival to consultation (numeric: 0–600 min) | Exit interview |
| Provider | ||
| Provider sex | Gender (male or female) | Observation |
| Job qualification | Doctor/clinical officer/technician or medical assistant or nurse/midwife/HSA | Observation |
| Supervisor status | Supervisor or in-charge (yes or no) | Provider interview |
| Experience | Year received current job qualification (numeric: 1950–2014) | Provider interview |
| Work hours | Average work hours per week (numeric: 1–90 h per week) | Provider interview |
| Training | RDT training (ever received or not) | Provider interview |
| Training | IMCI training (ever received or not) | Provider interview |
| Supervision | Provider supervision (ever received or not) | Provider interview |
| Supervision quality | Discussed work issues during most recent supervisory visit (yes or no) | Provider interview |
| Facility | ||
| Malaria risk | P | Malaria Atlas Project |
| Transmission season | Transmission season (peak or off-peak) | MARA |
| Location | Residence (urban or rural) | Facility audit |
| Region | Region (central or north or south) | Facility audit |
| Facility type | Hospital (central, district, rural, other) or other facility (centre, post, dispensary, clinic) | Facility audit |
| Managing authority | Government or CHAM/other | Facility audit |
| Management | Routine management meetings (yes or no) | Facility audit |
| Staffing | Total staff doctors (numeric: 0–119) | Facility audit |
| External supervision | External supervisory visit to facility (ever received or not) | Facility audit |
| User fees | Routine general user fees (yes or no) | Facility audit |
| Medicine stocks | Antibiotic (any type available or not) | Facility audit |
| Medicine stocks | Anti-malarial (any type available or not) | Facility audit |
| Supply stocks | RDT (observed valid or not in either service area or laboratory) | Facility audit |
| Supply stocks | Facility or staff timer (available or not) | Facility audit |
| Guidelines | RDT job aid or guidelines (available or not) | Facility audit |
| Guidelines | IMCI guidelines (available or not) | Facility audit |
Fig. 2Other complaints among clients with fever complaints, Malawi health facilities, 2013–2014. Totals may not sum to 1981 cases due to multiple reported symptoms. Any danger sign was reported in 1021 (52 %) of these observations. Symptom complaints are based on caregiver reports during exit interviews. Fever alone is without any other reported complaint or danger sign
Assessments of clients with fever complaints, Malawi health facilities, 2013–2014
| N Assessed | % Assessed (95% CI) | |
|---|---|---|
|
|
| |
| Fever mentioned or asked about by provider | 1684 | 85.0 (82.8–87.2) |
| Temperature taken or body felt for hotness | 1386 | 70.0 (65.5–74.1) |
| RDT done prior to consultation or referral for malaria diagnosisa | 1426 | 72.0 (69.0–74.7) |
| Checked neck for stiffness | 44 | 2.2 (1.4–3.5) |
| Checked for pallor by looking at palms | 524 | 26.5 (23.5–29.6) |
| Looked into child’s mouth | 185 | 9.3 (7.4–11.6) |
| Undressed child to examine (up to shoulders/down to ankles) | 563 | 28.4 (25.2–31.9) |
|
|
| |
| Both symptoms mentioned or asked about by provider | 1010 | 70.3 (66.7–73.7) |
| Counted breaths for 60 s | 256 | 17.8 (14.8–21.2) |
|
|
| |
| Both symptoms mentioned or asked about by provider | 307 | 53.9 (48.3–59.4) |
| Checked skin turgor for dehydration | 98 | 17.3 (13.3–22.1) |
Symptom complaints are based on caregiver reports during exit interviews. Completed assessments are based on recorded observations during consultations
aRDT done prior to consultation is based on provider reports that RDT was done prior to the consultation. Referral for malaria diagnosis is based on caregiver reports during the exit interview that the provider who treated the child instructed him/her to take the child to see another provider, or to go to the laboratory in this facility for a finger or heel stick for blood to be taken for testing
Anti-malarial and antibiotic prescriptions for clients with fever complaints, Malawi health facilities, 2013–2014
| N | % prescribed treatment (95% CI) | |
|---|---|---|
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| First-line anti-malarial prescription | 265 | 85.1 (77.5–90.4) |
| Second-line anti-malarial prescription | 22 | 7.0 (4.4–10.8) |
| No anti-malarial prescription | 25 | 7.9 (3.6–16.7) |
|
|
| |
| Any anti-malarial prescription (over-treatment) | 44 | 10.2 (6.8–14.9) |
|
|
| |
|
|
| |
| First-line antibiotic prescription | 148 | 39.4 (32.3–46.9) |
| Second-line antibiotic prescription | 123 | 32.7 (26.3–39.8) |
| No antibiotic prescription | 105 | 27.9 (20.7–36.5) |
|
|
| |
| Any antibiotic prescription (over-treatment) | 830 | 58.8 (55.1–62.4) |
Table 1 defines assessments and treatments reported in the above table. Anti-malarial under-treatment is defined as no anti-malarial prescription for an RDT-positive result. Anti-malarial over-treatment is defined as any anti-malarial prescription for an RDT-negative result. Antibiotic under-treatment is defined as no antibiotic prescription for a positive IMCI pneumonia classification. Antibiotic over-treatment is defined as any antibiotic prescription ‘without antibiotic need’, which excludes clients with IMCI-pneumonia based on re-examination and additionally excludes clients given the following diagnoses during the consultation: sepsis, acute ear infection, mastoiditis, dysentery, abscess, or severe malnutrition
Fig. 3Inter-relationship between RDT result (a) or RDT done (b) and other input variables on antibiotic over-treatment, Malawi health facilities, 2013–2014. CDB refers to cough or difficult breathing complaint. AB refers to antibiotic. Table 2 lists all input variables included in the model-based recursive partitioning analysis